Article(id=1325194071983136978, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325194058435534992, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.07.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1753718400000, receivedDateStr=2025-07-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793880487676, onlineDateStr=2026-11-05, pubDate=1783612800000, pubDateStr=2026-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793880487676, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793880487676, creator=13701087609, updateTime=1793880487676, updator=13701087609, issue=Issue{id=1325194058435534992, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='7', pageStart='743', pageEnd='876', issueExtLink='null', onlineDate='null', pubDate='1783612800000', pubDateStr='2026-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793880484446, creator='13701087609', updateTime=1793935292456, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325423940356670181, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325194058435534992, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325423940360864486, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325194058435534992, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=756, endPage=763, ext={EN=ArticleExt(id=1325194072197046483, articleId=1325194071983136978, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress on the Synthesis of Vaborbactam, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

Vaborbactam(1) is a novel boron-containing β-lactamase inhibitor. Used in combination with meropenem, it can treat complicated urinary tract infections. This combination therapy exhibits a favorable safety profile and robust clinical efficacy alongside substantial market demand, making research into its industrial synthetic routes highly significant. This review summarizes the currently reported synthetic routes of 1. One category of routes firstly utilized chiral enzymatic resolution to obtain the enantiomer tert-butyl (R)-3-hydroxy-4-pentenoate, followed by a Matteson reaction to construct the chiral boronate intermediate. Adopting continuous flow technology for the Matteson reaction can improve efficiency and safety. Another category of routes utilizes Ellman chiral imines for asymmetric borane addition to highly selectively generate the chiral boronate intermediate, which then undergoes deprotection and cyclization to yield the target 1. These routes feature readily available starting materials, mild conditions, as well as safety and environmental friendliness.A NiH-catalyzed hydroamidation route can prepare the chiral boronate intermediate from alkenyl boronic esters in a single step without the need for chiral auxiliaries or precious metal catalysts, but it is not suitable for industrial production. This paper compares and analyzes the advantages and limitations of various synthetic routes, and proposes that the synthesis of compound 1should be optimized toward fewer reaction steps, higher yields, milder reaction conditions and greener manufacturing processes.

, authors=Hongxia TANG1, 2, Jiawei LIANG1, authorsList=Hongxia TANG, Jiawei LIANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325194072691974356, articleId=1325194071983136978, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=法硼巴坦的合成研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

法硼巴坦(1)是一种含硼的新型β-内酰胺酶抑制剂,与美罗培南联用可治疗复杂性尿路感染。上述2种药物的复方制剂具有良好的安全性及疗效,市场需求大,因此研究1的工业化合成方法具有重要意义。文章归纳了目前报道的1合成路线。一类路线是先经手性酶拆分,得对映异构体(R)-3-羟基-4-戊烯酸叔丁酯,再经Matteson反应构建手性硼酯中间体。采用连续流工艺进行Matteson反应,可提高效率和安全性。另一类路线是利用Ellman手性亚胺进行不对称硼烷加成,高选择性地生成手性硼酯中间体,再经脱保护、环化得目标产物1。该路线原料易得、条件温和、安全环保。通过NiH催化氢酰胺化的路线可一步由烯基硼酸酯制备手性硼酯中间体,无需手性辅剂或贵金属催化剂,但不适合工业化生产。该文对比分析了不同路线的优势与局限性,期望1的合成可向步骤简化、效率提高、条件温和及工艺绿色化的方向发展。

, authors=汤红霞1, 2, 梁嘉伟1, authorsList=汤红霞, 梁嘉伟, authorCompany=null, correspAuthors=null, authorNote=

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=o6j5QFOHBxl8VXHN129Rcg==, magXml=fsaIDNUmQM+ga4d4OP+Q6w==, pdfUrl=null, pdf=XMJ7Ek37P5eCCHIxnoKbfw==, pdfFileSize=1015141, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=beosVa5ZTO/1Fv5hLyK4iA==, mapNumber=null, fund=null)}, authors=[Author(id=1325194073056878812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325194073170125023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073056878812, language=EN, stringName=Hongxia TANG, firstName=Hongxia, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1. Taizhou Hospital of Zhejiang Province, Linhai 317000
2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325194073245622496, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073056878812, language=CN, stringName=汤红霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.浙江省台州医院,浙江 临海 317000
2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000, bio={"content":"

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

"}, bioImg=null, bioContent=

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325194072901689557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=1., ext=[AuthorCompanyExt(id=1325194072910078166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Taizhou Hospital of Zhejiang Province, Linhai 317000), AuthorCompanyExt(id=1325194072918466775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江省台州医院,浙江 临海 317000)]), AuthorCompany(id=1325194072985575640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=2., ext=[AuthorCompanyExt(id=1325194072993964249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000), AuthorCompanyExt(id=1325194073002352858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000)])]), Author(id=1325194073321119970, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325194073392423140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073321119970, language=EN, stringName=Jiawei LIANG, firstName=Jiawei, middleName=null, lastName=LIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. Taizhou Hospital of Zhejiang Province, Linhai 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325194073463726309, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073321119970, language=CN, stringName=梁嘉伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江省台州医院,浙江 临海 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325194072901689557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=1., ext=[AuthorCompanyExt(id=1325194072910078166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Taizhou Hospital of Zhejiang Province, Linhai 317000), AuthorCompanyExt(id=1325194072918466775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江省台州医院,浙江 临海 317000)])])], keywords=[Keyword(id=1325194073560195302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=1, keyword=vaborbactam), Keyword(id=1325194073635692775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=2, keyword=urinary tract infection), Keyword(id=1325194073740550376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=3, keyword=bacterial pneumonia), Keyword(id=1325194073803464937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=4, keyword=synthesis), Keyword(id=1325194073866379498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=5, keyword=flow chemistry), Keyword(id=1325194073933488363, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=6, keyword=asymmetric synthesis), Keyword(id=1325194075607015660, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=EN, orderNo=7, keyword=research progress), Keyword(id=1325194075699290349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=1, keyword=法硼巴坦), Keyword(id=1325194075783176430, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=2, keyword=尿路感染), Keyword(id=1325194075862868207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=3, keyword=细菌性肺炎), Keyword(id=1325194075938365680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=4, keyword=合成), Keyword(id=1325194076009668849, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=5, keyword=流动化学), Keyword(id=1325194076085166322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=6, keyword=不对称合成), Keyword(id=1325194076143886579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, language=CN, orderNo=7, keyword=研究进展)], refs=[Reference(id=1325194076353601781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Duda-Madej A, Viscardi S, Topola E.Meropenem/vaborbactam: β-lactam/β-lactamase inhibitor combination,the future in eradicating multidrug resistance [J].Antibiotics(Basel), 2023, 12 (11): 1612., articleTitle=null, refAbstract=null), Reference(id=1325194076445876470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Hillyer T, Shin W S.Meropenem/vaborbactam: a mechanistic review for insight into future development of combinational therapies [J].Antibiotics(Basel), 2024, 13(6): 472., articleTitle=null, refAbstract=null), Reference(id=1325194076512985335, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Bouza E.The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections [J].J Antimicrob Chemother, 2021, 76(Suppl 4): iv38-iv45., articleTitle=null, refAbstract=null), Reference(id=1325194076596871416, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Lupia T, Corcione S, Shbaklo N, et al.Meropenem/vaborbactam and cefiderocol as combination or monotherapy to treat multi-drug resistant gram-negative infections: a regional cross-sectional survey from piedmont infectious disease unit network(PIDUN) [J].J Funct Biomater, 2022,13(4): 174., articleTitle=null, refAbstract=null), Reference(id=1325194076659785977, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=斯日古楞, 刘欢欢, 乌日汗, 等. 新型抗菌药物及其治疗方式的研究进展[J].世界临床药物, 2022, 43(9): 1078-1086., articleTitle=null, refAbstract=null), Reference(id=1325194076722700538, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Grams R J, Santos W L, Scorei I R, et al.The rise of boron-containing compounds: advancements in synthesis, medicinal chemistry, and emerging pharmacology [J].Chem Rev, 2024,124(5): 2441-2511., articleTitle=null, refAbstract=null), Reference(id=1325194076810780923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Prates J L B, Pavan A R, dos Santos J L.Boron in medicinal and organic chemistry [J].Curr Org Chem, 2021, 25(16):1853-1867., articleTitle=null, refAbstract=null), Reference(id=1325194076869501180, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Hecker S J, Reddy K R, Totrov M, et al.Discovery of a cyclic boronic acid β-lactamase inhibitor(RPX7009) with utility vs class a serine carbapenemases [J].J Med Chem,2015, 58(9): 3682-3692., articleTitle=null, refAbstract=null), Reference(id=1325194076953387261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamamoto Y, Fujikawa R, Umemoto T, et al.Iridium-catalyzed hydroboration of alkenes with pinacolborane [J].Tetrahedron, 2004, 60(47): 10695-10700., articleTitle=null, refAbstract=null), Reference(id=1325194077028884734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Blieck R, de la Torre A.1,2-Boronate rearrangement: an efficient tool for the opening, functionalization and formation of strained cycles [J].Eur J Org Chem, 2022, 2022(41): 70-86., articleTitle=null, refAbstract=null), Reference(id=1325194077100187903, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Essman J Z, Sharma H A, Jacobsen E N.Development of enantioselective lithium-isothiourea-boronate-catalyzed matteson homologations [J].Synlett, 2023, 34(18): 2061-2070., articleTitle=null, refAbstract=null), Reference(id=1325194077188268288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Vrielynck S, Vandewalle M, García A M, et al.A chemoenzymatic synthesis of a-ring key-intermediates for 1α,25-dihydroxyvitamin d3 and analogues [J].Tetrahedron Lett, 1995, 36(49): 9023-9026., articleTitle=null, refAbstract=null), Reference(id=1325194077255377153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Hecker S, Boyer S.Synthesis of boronate salts and uses thereof: US15/305954 [P].2019-08-20., articleTitle=null, refAbstract=null), Reference(id=1325194077326680322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Stueckler C, Hermsen P, Ritzen B, et al.Development of a continuous flow process for a matteson reaction: from lab scale to full-scale production of a pharmaceutical intermediate[J].Org Process Res Dev, 2019, 23 (5): 1069-1077., articleTitle=null, refAbstract=null), Reference(id=1325194077397983491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=王保林, 戚聿新, 徐欣, 等.一种法硼巴坦的简便制备方法:CN201811191076.1 [P].2020-12-01., articleTitle=null, refAbstract=null), Reference(id=1325194077465092356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=王保林, 戚聿新, 刘月盛, 等.一种3-羟基-6-氧代己酸酯的制备方法: CN201811202269.2 [P].2021-08-17., articleTitle=null, refAbstract=null), Reference(id=1325194077548978437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=王猛, 蒋健, 王方道, 等.一种法硼巴坦的制备方法:CN202411895833.9 [P].2025-03-28., articleTitle=null, refAbstract=null), Reference(id=1325194077616087302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang Y, Qiao D, Duan M, et al.Enantioselective synthesis of α-aminoboronates by NiH-catalysed asymmetric hydroamidation of alkenyl boronates [J].Nat Commun,2022, 13(1): 5630., articleTitle=null, refAbstract=null), Reference(id=1325194077699973383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=朱少林, 张遥.一种镍催化的不对称氢酰胺化制备手性α-氨基硼酸/硼酸酯的方法: CN202210526440.5 [P].2024-03-19., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325194076248744180, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, awardId=22ywb12, language=CN, fundingSource=台州市社会发展科技计划项目(22ywb12), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325194072901689557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=1., ext=[AuthorCompanyExt(id=1325194072910078166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Taizhou Hospital of Zhejiang Province, Linhai 317000), AuthorCompanyExt(id=1325194072918466775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江省台州医院,浙江 临海 317000)]), AuthorCompany(id=1325194072985575640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=2., ext=[AuthorCompanyExt(id=1325194072993964249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000), AuthorCompanyExt(id=1325194073002352858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.07.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.07.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.07.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.07.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1783612800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
法硼巴坦的合成研究进展
汤红霞 1, 2 , 梁嘉伟 1
中国医药工业杂志 | 专论与综述 2026,57(7): 756-763
收起
收藏切换
中国医药工业杂志 |专论与综述 2026 , 57 (7) : 756 -763
法硼巴坦的合成研究进展
全屏
[Author(id=1325194073056878812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325194073170125023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073056878812, language=EN, stringName=Hongxia TANG, firstName=Hongxia, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1. Taizhou Hospital of Zhejiang Province, Linhai 317000
2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325194073245622496, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073056878812, language=CN, stringName=汤红霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.浙江省台州医院,浙江 临海 317000
2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000, bio={"content":"

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

"}, bioImg=null, bioContent=

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325194072901689557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=1., ext=[AuthorCompanyExt(id=1325194072910078166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Taizhou Hospital of Zhejiang Province, Linhai 317000), AuthorCompanyExt(id=1325194072918466775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江省台州医院,浙江 临海 317000)]), AuthorCompany(id=1325194072985575640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=2., ext=[AuthorCompanyExt(id=1325194072993964249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000), AuthorCompanyExt(id=1325194073002352858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072985575640, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000)])]), Author(id=1325194073321119970, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325194073392423140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073321119970, language=EN, stringName=Jiawei LIANG, firstName=Jiawei, middleName=null, lastName=LIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. Taizhou Hospital of Zhejiang Province, Linhai 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325194073463726309, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, authorId=1325194073321119970, language=CN, stringName=梁嘉伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.浙江省台州医院,浙江 临海 317000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325194072901689557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, xref=1., ext=[AuthorCompanyExt(id=1325194072910078166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Taizhou Hospital of Zhejiang Province, Linhai 317000), AuthorCompanyExt(id=1325194072918466775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325194071983136978, companyId=1325194072901689557, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.浙江省台州医院,浙江 临海 317000)])])]
汤红霞1, 2, 梁嘉伟1
作者信息
  • 1.浙江省台州医院,浙江 临海 317000
  • 2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000
作者简介:

汤红霞,临床药师,硕士,从事新型药物靶向递送系统及药物合成的研究。

Research Progress on the Synthesis of Vaborbactam
Hongxia TANG1, 2, Jiawei LIANG1
Affiliations
  • 1. Taizhou Hospital of Zhejiang Province, Linhai 317000
  • 2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000
出版时间: 2026-07-10 doi: 10.16522/j.cnki.cjph.2026.07.002
文章导航
收藏切换

法硼巴坦(1)是一种含硼的新型β-内酰胺酶抑制剂,与美罗培南联用可治疗复杂性尿路感染。上述2种药物的复方制剂具有良好的安全性及疗效,市场需求大,因此研究1的工业化合成方法具有重要意义。文章归纳了目前报道的1合成路线。一类路线是先经手性酶拆分,得对映异构体(R)-3-羟基-4-戊烯酸叔丁酯,再经Matteson反应构建手性硼酯中间体。采用连续流工艺进行Matteson反应,可提高效率和安全性。另一类路线是利用Ellman手性亚胺进行不对称硼烷加成,高选择性地生成手性硼酯中间体,再经脱保护、环化得目标产物1。该路线原料易得、条件温和、安全环保。通过NiH催化氢酰胺化的路线可一步由烯基硼酸酯制备手性硼酯中间体,无需手性辅剂或贵金属催化剂,但不适合工业化生产。该文对比分析了不同路线的优势与局限性,期望1的合成可向步骤简化、效率提高、条件温和及工艺绿色化的方向发展。

法硼巴坦  /  尿路感染  /  细菌性肺炎  /  合成  /  流动化学  /  不对称合成  /  研究进展

Vaborbactam(1) is a novel boron-containing β-lactamase inhibitor. Used in combination with meropenem, it can treat complicated urinary tract infections. This combination therapy exhibits a favorable safety profile and robust clinical efficacy alongside substantial market demand, making research into its industrial synthetic routes highly significant. This review summarizes the currently reported synthetic routes of 1. One category of routes firstly utilized chiral enzymatic resolution to obtain the enantiomer tert-butyl (R)-3-hydroxy-4-pentenoate, followed by a Matteson reaction to construct the chiral boronate intermediate. Adopting continuous flow technology for the Matteson reaction can improve efficiency and safety. Another category of routes utilizes Ellman chiral imines for asymmetric borane addition to highly selectively generate the chiral boronate intermediate, which then undergoes deprotection and cyclization to yield the target 1. These routes feature readily available starting materials, mild conditions, as well as safety and environmental friendliness.A NiH-catalyzed hydroamidation route can prepare the chiral boronate intermediate from alkenyl boronic esters in a single step without the need for chiral auxiliaries or precious metal catalysts, but it is not suitable for industrial production. This paper compares and analyzes the advantages and limitations of various synthetic routes, and proposes that the synthesis of compound 1should be optimized toward fewer reaction steps, higher yields, milder reaction conditions and greener manufacturing processes.

vaborbactam  /  urinary tract infection  /  bacterial pneumonia  /  synthesis  /  flow chemistry  /  asymmetric synthesis  /  research progress
汤红霞, 梁嘉伟. 法硼巴坦的合成研究进展. 中国医药工业杂志, 2026 , 57 (7) : 756 -763 . DOI: 10.16522/j.cnki.cjph.2026.07.002
Hongxia TANG, Jiawei LIANG. Research Progress on the Synthesis of Vaborbactam[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (7) : 756 -763 . DOI: 10.16522/j.cnki.cjph.2026.07.002
  • 台州市社会发展科技计划项目(22ywb12)
参考文献 引证文献
排序方式:
[1]
Duda-Madej A, Viscardi S, Topola E.Meropenem/vaborbactam: β-lactam/β-lactamase inhibitor combination,the future in eradicating multidrug resistance [J].Antibiotics(Basel), 2023, 12 (11): 1612.
[2]
Hillyer T, Shin W S.Meropenem/vaborbactam: a mechanistic review for insight into future development of combinational therapies [J].Antibiotics(Basel), 2024, 13(6): 472.
[3]
Bouza E.The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections [J].J Antimicrob Chemother, 2021, 76(Suppl 4): iv38-iv45.
[4]
Lupia T, Corcione S, Shbaklo N, et al.Meropenem/vaborbactam and cefiderocol as combination or monotherapy to treat multi-drug resistant gram-negative infections: a regional cross-sectional survey from piedmont infectious disease unit network(PIDUN) [J].J Funct Biomater, 2022,13(4): 174.
[5]
斯日古楞, 刘欢欢, 乌日汗, 等. 新型抗菌药物及其治疗方式的研究进展[J].世界临床药物, 2022, 43(9): 1078-1086.
[6]
Grams R J, Santos W L, Scorei I R, et al.The rise of boron-containing compounds: advancements in synthesis, medicinal chemistry, and emerging pharmacology [J].Chem Rev, 2024,124(5): 2441-2511.
[7]
Prates J L B, Pavan A R, dos Santos J L.Boron in medicinal and organic chemistry [J].Curr Org Chem, 2021, 25(16):1853-1867.
[8]
Hecker S J, Reddy K R, Totrov M, et al.Discovery of a cyclic boronic acid β-lactamase inhibitor(RPX7009) with utility vs class a serine carbapenemases [J].J Med Chem,2015, 58(9): 3682-3692.
[9]
Yamamoto Y, Fujikawa R, Umemoto T, et al.Iridium-catalyzed hydroboration of alkenes with pinacolborane [J].Tetrahedron, 2004, 60(47): 10695-10700.
[10]
Blieck R, de la Torre A.1,2-Boronate rearrangement: an efficient tool for the opening, functionalization and formation of strained cycles [J].Eur J Org Chem, 2022, 2022(41): 70-86.
[11]
Essman J Z, Sharma H A, Jacobsen E N.Development of enantioselective lithium-isothiourea-boronate-catalyzed matteson homologations [J].Synlett, 2023, 34(18): 2061-2070.
[12]
Vrielynck S, Vandewalle M, García A M, et al.A chemoenzymatic synthesis of a-ring key-intermediates for 1α,25-dihydroxyvitamin d3 and analogues [J].Tetrahedron Lett, 1995, 36(49): 9023-9026.
[13]
Hecker S, Boyer S.Synthesis of boronate salts and uses thereof: US15/305954 [P].2019-08-20.
[14]
Stueckler C, Hermsen P, Ritzen B, et al.Development of a continuous flow process for a matteson reaction: from lab scale to full-scale production of a pharmaceutical intermediate[J].Org Process Res Dev, 2019, 23 (5): 1069-1077.
[15]
王保林, 戚聿新, 徐欣, 等.一种法硼巴坦的简便制备方法:CN201811191076.1 [P].2020-12-01.
[16]
王保林, 戚聿新, 刘月盛, 等.一种3-羟基-6-氧代己酸酯的制备方法: CN201811202269.2 [P].2021-08-17.
[17]
王猛, 蒋健, 王方道, 等.一种法硼巴坦的制备方法:CN202411895833.9 [P].2025-03-28.
[18]
Zhang Y, Qiao D, Duan M, et al.Enantioselective synthesis of α-aminoboronates by NiH-catalysed asymmetric hydroamidation of alkenyl boronates [J].Nat Commun,2022, 13(1): 5630.
[19]
朱少林, 张遥.一种镍催化的不对称氢酰胺化制备手性α-氨基硼酸/硼酸酯的方法: CN202210526440.5 [P].2024-03-19.
2026年第57卷第7期
198
61
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.07.002
  • 接收时间:2025-07-29
  • 首发时间:2026-11-05
  • 出版时间:2026-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-07-29
基金
台州市社会发展科技计划项目(22ywb12)
作者信息
    1.浙江省台州医院,浙江 临海 317000
    2.台州市药物治疗与转化研究重点实验室,浙江 临海 317000
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.07.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏